Protonix Kidney Disease Class Action Lawsuit
Use of the acid reflux medication Protonix (generic: pantoprazole) may increase the risk of chronic kidney disease (CKD), a serious medical condition characterized by the gradual loss of kidney function. Free Confidential Lawsuit Evaluation: If you or a loved one...
Nexium Kidney Failure Class Action Lawsuit
Our lawyers are reviewing potential lawsuits for people who suffered kidney failure or acute interstitial nephritis (AIN) after taking Nexium (esomeprazole magnesium), a heartburn medication made by AstraZeneca. Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Nexium,...
Levaquin Class Action Lawsuit
Levaquin Settlement Update April 11, 2017 – Johnson & Johnson has been settling many lawsuits alleging nerve damage and peripheral neuropathy from Levaquin out of court, in some cases just days before trial. It stands to reason that J&J would...
Vimovo Class Action Lawsuit
Update: Acid Reflux Drugs May Double Risk of Stomach Cancer, Study Finds December 1, 2017 – Long-term use of PPIs can increase your risk of stomach cancer by up to 250%, a new study published in the journal Gut has...
Zegerid Class Action Lawsuit
Update: Zegerid May Double Your Risk for Stomach Cancer, Study Finds December 1, 2017 – Proton pump inhibitors like Zegerid have been linked to a more than doubled risk for stomach cancer, a new study published in the medical journal...
Dexilant Class Action Lawsuit
Update: PPI Acid Reflux Drugs Increase Stomach Cancer Risk by up to 250%, Study Finds December 1, 2017 – Extended use of PPIs (3 years or more) can elevate your risk of stomach cancer by up to 250%, a new...
Protonix Class Action Lawsuit
Update: PPI Heartburn Medicines Linked to Dermatological Reactions, Study Finds October 23, 2017 – A case report presented at this year’s meeting of the American College of Gastroenterology found that the proton pump inhibitors pantoprazole (Protonix) and lansoprazole (Prevacid) were...
Prevacid Class Action Lawsuit
Update: Long-Term PPI Use Linked to Doubled Risk for Gastric Cancer December 1, 2017 – Use of a proton-pump inhibitor like Prevacid after Helicobacter pylori eradication more than doubles your risk for stomach cancer, according to a new study published...